chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client reports that after she got the covid vaccine, her lips and her mouth felt tingly.  PHN monitoring her gave her some benedryl.  The next day she did not feel well.  She had bodyaches and diarrhea.  She reports in the morning she could not move her arms and legs.  Her brain kept telling them to move but they would not move.  She did go to the doctor and to see an allergist because she wants to get the second one but no one can seem to say yes or no she should get it.
Nausea, dizzy, hot flashes, chills, gastrointestinal upset
30 minutes post vax, the pt experienced itching at the injection site. She was treated with Benadryl and the itching cleared in 90 minutes. The most recent information received reports the outcome of the event as resolved.
This spontaneous report as received from a pharmacist, via a company representative, refers to a currently 65 years old female patient with hypertension. Medical and concurrent conditions were not reported. On an unknown date approximately in 2011 (reported as "about 4 years ago"), the patient was vaccinated with a dose of ZOSTAVAX (administration route, lot number and expiration date were not reported). The reporting pharmacist stated that the patient was taking unspecified blood pressure medications (at the time of the report). On an unknown date (reported as "before last month"), the patient developed herpes zoster and was treated with an unspecified anti-viral. The outcome of herpes zoster was reported as recovered (the reporter stated that the patient was "doing fine now") on an unspecified date. Additional information is not expected because the reporter refuses to be contacted.
Day 2, redness at shot site, shoulder muscles pain, weak and tired, headache, shivering, day 3, redness and very sore at shot site, rash on arms chest, stomach, back and legs, very tired, small headache, day 4, sore at shot site and still have rash, day 5, rash better but still evident, arm still sore but better.
A couple of days after vaccine had slight reactions which were not problematic.  Six days following vaccination the site red, itchy and swollen ( approx. bigger than palm of hand).  No treatment.  Continues to have symptoms noted prior.
Day 1 (day of vaccination): dry mouth Day 2: pain in left arm and body aches Day 3: none Day 4 (today): tingling in lips and mouth, swelling of left side of face with numbness
6cm round, hot, red, raised, painful inj site x 6 days;onset 12hr p/vax;
TEMPERATURE EXCURSION OCCURRED DUE TO THE PLACEMENT OF HAND WARMERS IN THE INSULATED BAG USED TO TRANSPORT VACCINE. ALL 81 PERSONS RECEIVING VACCINE IN LANES 5 AND 6 AT THE VACCINATION SITE ON 02/15/2021 BETWEEN 14:00 and 16:45 WERE NOTIFIED THEY  RECEIVED VACCINE THAT WAS OUTSIDE OF THE APPROPRIATE TEMPERATURE RANGE AND WERE RECOMMENDED TO BE REVACCINATED.
SKIN ITCHING/PEELING. PT STATES THAT IT RESOLVES AND THEN COMES BACK
pt recv vax 8NOV96 & 22NOV96 pt devel flu-like sx, including chills & fever, & pain, redness, warmth, & swelling @ inj site;pt recovered from sx;
This spontaneous case, initially received from other health professional (combinedly processed with follow-up) on 17-Oct-2018, concerns a female patient of unspecified age. The patient had no medical history and concomitant medications. It was reported that the plunger got stucked and was not moved even with a lot pressure applied. On 12-Oct-2018, the patient was administered partial dose of FLUCELVAX QIVc [dose: half dose (0.5 ml as reported), route of administration: intramuscular, anatomical location: deltoid, batch number: 252656 and expiry date: 31-May-2019], with a pre-filled syringe (PFS) with plunger issue. This case was associated with product quality complaint, hence quality assurance investigation (QAI) had been requested and the corresponding PTC reference number was (PTC number: 1034396). No adverse events were reported after the vaccine administration. The reporter assessed the case as non-serious. Non-significant follow-up received from the other health professional on 17-Nov-2018: The reporter confirmed that the patient did not experienced any adverse event after the vaccine administration and did not have any further information to provide about the patient or the case. No changes were made in the narrative.
Pain in my right arm/shoulder has persisted for two months. I have limited mobility and tense pain if moved in above my head or around my back.  The 2nd dose was in my left arm and there are no issues with this vaccine.
joint pain; body feels feverish; injection site soreness; This is a spontaneous report from a contactable pharmacist (patient).   A 42-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route of administration, administered in Arm Left on 14Apr2021 at 09:30 (age at the time of vaccination was 42 years) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Reportedly, the patient did not have any known allergies. Previously, the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route of administration, administered in Arm Left on 24Mar2021 at 09:30 (age at the time of vaccination was 42 years) as single dose for COVID-19 immunisation and experienced Injection site soreness. No other vaccines were received by the patient in four weeks. Reportedly, the patient did not have covid prior vaccination. On 14Apr2021, the patient experienced injection site soreness. On 15Apr2021 at 03:00, the patient experienced joint pain and body feels feverish. Reportedly, after 2nd injection the patient experienced injection site soreness that started a couple hours after vaccine. Approximately 18 hours after the injection, joint pain started, and body felt feverish, but did not have a fever. These symptoms went away approximately 36 hours after the injection. No treatment was received for events. The patient was not tested for COVID post vaccination. The outcome of all the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Patient given a second dose of Tdap on 05-07-2007.  Initial dose of Tdap given 09-08-2006. Patient experienced a sore left arm with warmth and redness at injection site lasting 48 hours.  No further problems following vaccination. No treatment was given.
I get an upset stomach after I eat. I will get sick for hours and must lay down for a while. I went the doctor, and they did several tests. The tests came back normal. I am still having this problem.
I vaccinated the patient with the Pfizer Covid-19 vaccine. Immediately afterwards, I noticed some bleeding and then a few seconds later I noticed a welt(swelling) start to form. It appeared to become slightly larger over the next couple minutes. It felt quite firm to the touch. However, the patient denied it being painful. The lump did not appear red or inflamed. I immediately applied a cotton ball and held gentle pressure; this was to stop the small amount of bleeding. After removing the cotton ball a few seconds later, I noticed the unusual swelling. I immediately notified the staff that I required a RN's assistance. I monitered the patient, and then asked my line leader (supervisor) to continue to moniter him as I had to continue vaccinating other patients. A couple minutes later, the RN came over and took over the situation. Patient's breathing was normal & did not appear to be in distress. Patient was then directed to drive to the Medical survellance outside.
she cant hold down anything but a sip of water; severe dizziness; Headache; Nauseous; This is a spontaneous report received from a contactable consumer reported for a female patient (Sister). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 13Feb2021 as unknown, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 16Feb2021, the patient cant hold down anything but a sip of water, had severe dizziness, headache and nauseous. It was reported that patient took the vaccine on Saturday and yesterday experienced severe headaches, nauseous, and severe dizziness; she cant hold down anything but a sip of water. The outcome of events was unknown.   Follow-up attempts are completed. No further information is expected.
One of the nurses at our office administered the covid vaccine without diluting and mixing it. The vaccine was drawn up front the vial and given with no diluent. So far, patient has not experienced any adverse events. The parent was notified and notified to watch for exaggerated side effects.
pt recv vax 22JAN97 & pt broke out in red, raised areas on hands & feet; c/o of itching;denies problems breathing red, raised areas & itching extended to arms, neck, back on 24JAN97;pt contacted MD;recommended DPH to be taken;
Patient's arm started to hurt and has remained red, warm, slightly swollen, there is a knot in the center (injection site) and is painful when used.  This has lasted in his right arm since right after his shot on 10.31.2021 and it has not improved.  He did not have this reaction with the first two doses.  He wanted a report made, as it was unusual and is not improving and he never experienced this with any other vaccine.
A serious (grade 3) report of weight loss and persistent vomiting was received from an investigator concerning an eight-year-old male subject who was enrolled in the investigator initiated trial. The subject's medical history and concomitant medications were not reported. The subject received FLUMIST on 25-Sep-2008. On 28-Sep-2008, the subject started vomiting and continued to vomit. On 07-Oct-2008, the subject was seen by his physician who noted weight loss of nine pounds. The subject was hospitalized. Information regarding hospital course was not reported. The events were ongoing. The investigator assessed the events as possibly related to FLUMIST. The attending physician determined that the events were not likely to be related to FLUMIST.
Eleven days after receiving one dose of varicella virus vaccine live the pt developed a fever of 100.6F and several vesicle including 3-4 near pts eye that caused it to swell.
localized redness @ site of inj rt upper arm approx 2-3" around;no other signs or sx;
Racing heart and anxiety attack at 0400. Woke up in the middle of the night with BP of 150/90 and heart rate of 180. Ambulance was called and diagnosed with heart palpitations from the vaccine.
12 hours after vaccine started to have congestion, hives/welts (50-cent piece size) on head, neck and chest, itching, difficulty breathing, "bronchial asthma-type symptoms", GI cramping, throat felt like it was closing. She is still having difficulty breathing, congestion, itching, and hives are still present.
Received Flu shot at pharmacy 11/11 and arm was sore for 2 days then felt fine. 11/18 site was very painful and remained so getting worse each day.
Hives on arms then followed to back and then under eyes; Light fever; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 10:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient did not have medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication within two weeks prior to the vaccination. On 26Apr2021, the patient experienced light fever. On the same day, the patient underwent a body temperature test and the result was 37.4 degrees Centigrade. On 05May2021 at 14:00, the patient experienced hives on arms then followed to back and then under eyes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event light fever was resolved on an unknown date in 2021 while that of the event hives on arms then followed to back and then under eyes was resolved on 05May2021, after the duration of 3 hours.  No follow-up attempts are needed. No further information is expected.
pain in right hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Apr2021 16:30 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 15Apr2021, outcome "unknown", described as "pain in right hand".  Additional information: Caller states that she just had the Pfizer COVID vaccine yesterday 15Apr2021 at about 4:30pm and when she got home around 7:00 PM or 8:00 PM her right hand was hurting. Caller states that it is not really a sharp pain. Caller states that she got the Pfizer COVID vaccine in the left arm.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Administered vaccine, pt requested receipt, left pt to retrieve paperwork, returned to pt within 5 min and pt appeared unconscious, difficult to arouse, then came around and stared off.  Unable to state where she was, lived, did not recall getting shots. BP was 147/76; called EMS--over 45min period she seemed to become more aware to her surroundings, released to EMS.
lupoid rash over bridge of nose 23APR95; bilateral tenosynovitis hands 28APR95 sx less than 24 hr;
Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for COVID). At the time of the report, COVID-19 (Tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) tested positive for COVID.         Concomitant product information was not provided.  Treatment information was not provided.
Left axillary lymphadenopathy; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 22-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EJ1686/expiration date: not provided), via intramuscular route of administration, on an unknown date as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were not provided. The patient previously received the first dose of BNT162B2 (lot number EH9899) on an unknown date for COVID-19 immunization. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Jan2021, the patient experienced left axillary lymphadenopathy. The patient did not receive any treatment for the event. The event left axillary lymphadenopathy was assessed as non-serious. The outcome of the event left axillary lymphadenopathy was not recovered. Since the vaccination, the patient had not been tested for COVID-19.
Developed L neck pain, stiffness, decreased ROM and headache within minutes of receiving FLUZONE vaccination.
no additional adverse event; expired dose was given to a patient; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided.  On 28-SEP-2022, the patient was vaccinated with one expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) injection, at a dose of 0.5 ml, lot # T032761 confirmed to be valid with expiration date 30-MAY-2022 (conflicting information, expiration date also reported as 30-JUN-2022) (dose number, route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). The vaccine did not undergo any temperature excursion. There was no additional adverse event and no PQC reported.
pt recvd vax & whole body was shivering; t 103; flushed & hives all over legs & arms; red & raised size of quarters; shaking; 17oct h/a cont;
soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and 006M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (soreness). At the time of the report, PAIN (soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. Treatment information was not reported.    This case was linked to MOD-2021-029567 (Patient Link).   Reporter did not allow further contact
High fever 104-105 rash 4 days after high fever (twin sib had febrile seizure above twin admitted due to high temp, similar symptoms. 6/8/06 Received medical records from hospital which reveal patient experienced Temp 104.9 with no seizures.  Twin sibling also admitted  but with febrile seizures.  Patient's exam while hospitalized revealed seizures, congested nasopharynx. Final dx: viral syndrome/ss
9/23/23 1 pm at a Tent event in the parking lot at the front of the store.  Very busy event and did not just computers to double check ahead of the dose.  The Tech and this writer (RPh) veiwed the PCQF form and missed that this 8 year old 95 Lb child was incorrectly given the 12 years and older Spikevax vaccine and flu shot.  She was on the tail end of antibiotics for sinusitis and should note have been given a shot.  at 6:30 pm we realized there error because or computer/system would not allow the claim to even select due to the age of the patient.  at 6:35 PM this writer immediately called the grandmother to notify of this error. Patient had taken 480 mg of Acetaminophen at 5:30 pm and was sleeping.  Instructed grandma to give her fluids, Ibuprofen 200 mg at 8:30 pm and every 6 hours for inflammation , aches and fever, alternating with tylenol 3 hours later if needed.Instructed her that if any difficulty breathing (bluish finger tips, lips, high fever or non responsive to go to the ER or call 911.  On  Monday 9/25/23 called Provider to report what happened.  Called on 9/25/23 to Grandma to see how patient was doing.  Grandma shared that on Sunday 9/24 she alternated the ibuprofen and acetaminophen and the child was dizzy twice when she took a shower.  Her temperature was steady at 97.5 F and grandma's pulse oximeter showed 98-100%.  Patient reported on Sunday 9/24/23 it hurt to breathe but that she was able to breathe through the night. Grandma listened to her breathe all night and said it didn't sound bad and she did not feel the need to contact medical help.  On  Monday 9/25/23 at 10 AM, grandma said patient was doing better and had not had any tylenol since 8 PM last night.  It still hurt to breathe but that she was better.  Patient got on the phone and described that it hurt less today and "hurt where a necklace would be."  They were in the doctors office waiting room because Grandma just wanted to double check if she was doing OK. Shared that she could give another 200 mg of ibuprofen to help her feel comfortable or do what she thought was best.  Shared that I would use this information to the CDC VAERS program in case this error happened to someone else.  Grandma reported that the covid shot area had a 1 inche red itchy spot on her arm and the flu shot area had a 1 inch black and blue bruise.
THE CLIENT HAD ALREADY RECIEVED 2 DOSES OF MODERNA (ON 01/18/21 AND 02/18/21).  THE CLIENT INADVERTENTLY RECEIVED A THIRD DOSE OF COVID-19 VACCINE (PFIZER) ON 05/20/21.
GI upset ? 10pm 1/6 to 12pm 1/7 Headache, chills, myalgias? 8am 1/7 to 8am 1/8
COVID vaccine was Pfizer or Moderna, patient unsure. She developed pancolitis with symptoms starting 8 days post vaccine.
Body aches, progressing to headache this morning. This afternoon and currently having significant stomach pain, with some nausea. Symptoms, ( stomach ache ) ,seems to be lessening.. Have taken some ibuprofen, no other treatment sought at this time. Has now been about 24 hours post injection.
Narrative: A 25yo male with PMH of Hyperlipidemia, Chronic pain, Migraine and Chronic PTSD. immunization record indicated the patient received Pfizer Covid -19 vaccine on March 16, 2021 and recorded as series 1. Received 0.3ml IM. No other detailed information regarding the vaccine reported. On April 29, 2022 attending physician reported the patient had a historical ADR to Pfizer Covid - 19 vaccine which occurred on March 16, 2021. It was described as as an angioedema and urticarial which occurred within 10-15 minutes of the injection and resolved within 45 minutes. No other detailed information were provided regarding the product, who administered the vaccine and whether the patient received any treatments.
This case was reported by a consumer via call center representative and described the occurrence of hives in a 61-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received in September 2018). On 3rd March 2019, the patient received the 2nd dose of SHINGRIX (intramuscular). In March 2019, less than a month after receiving SHINGRIX, the patient experienced hives. On an unknown date, the outcome of the hives was not recovered/not resolved. It was unknown if the reporter considered the hives to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left arm. The patient reported hives breakout of legs after receiving dose of SHINGRIX. The reporter did not give consent to follow up. The caller refused medical doctor contact regarding this event.